SONN Sonnet BioTherapeutics Holdings Inc.
SONN Stock Analysis Overview
What this means: Sonnet BioTherapeutics Holdings Inc. (SONN) gets an Overall Rank of 57, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. SONN's 57 means that it ranks higher than 57% of stocks.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.
SONN Fundamental Analysis
Upgrade to Premium to unlock Fundamental Ranking
SONN Short-Term Technical Analysis
Upgrade to Premium to unlock Short-Term Technical Ranking
SONN Long-Term Technical Analysis
Upgrade to Premium to unlock Long-Term Technical Ranking
SONN Analyst Ranking
Upgrade to Premium to unlock Analyst Ranking Analysis
SONN Valuation Ranking Analysis
Upgrade to Premium to unlock Valuation Ranking
SONN Stock Sentiment Analysis
Upgrade to Premium to unlock Stock Sentiment Ranking
SONN Stock Analysis Overview
What this means: Sonnet BioTherapeutics Holdings Inc. (SONN) gets an Overall Rank of 57, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. SONN's 57 means that it ranks higher than 57% of stocks.
Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.